Capital Management (Tables)

12 Months Ended

Dec. 31, 2022

Corporate Information And Statement Of IFRS Compliance [Abstract]

Schedule of total capital

For regulatory reporting purposes under the LICAT framework, there were further adjustments, including goodwill, non-life investments, and others as prescribed by OSFI, to the total capital figure presented in the table below:

As at December 31,	2022			2021
Subordinated debt		$	6,676		$	6,425
Innovative capital instruments(1)		200			200
Equity:
Preferred shares and other equity instruments		2,239			2,239
Common shareholders’ equity(2)		25,211			24,075
Participating policyholders’ equity		1,837			1,700
Non-controlling interests’ equity		90			59
Total capital		$	36,253		$	34,698

(1)    Innovative capital instruments are SLEECS issued by SLCT I (Note 13). SLCT I is not consolidated by us.

(2)    Common shareholders' equity is equal to Total shareholders' equity less Preferred shares and other equity instruments